Long-Term Debt (Quarterly)

Long-Term Debt: The sum of all long term debt fields.

IDEXX Laboratories, Inc. (IDXX) had Long-Term Debt of $299.87M for the most recently reported fiscal quarter, ending 2026-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2026-06-30

Income Statement Financials
Revenue	$1.22B
Net Income	$338.41M
Cost of Goods Sold	$437.50M
Gross Profit	$779.09M
Operating Expenses	$791.02M
Operating Income	$425.57M
Non-Operating Income/Expense	$-8.34M
Pre-Tax Income	$417.22M
Normalized Pre-Tax Income	$417.22M
Income after Taxes	$338.41M
Income from Continuous Operations	$338.41M
Consolidated Net Income/Loss	$338.41M
Normalized Income after Taxes	$338.41M
EBIT	$425.57M
EBITDA	$466.62M
Weighted-Average Shares Outstanding (Basic)	78.95M
Weighted-Average Shares Outstanding (Diluted)	79.31M
Earnings per Share (EPS) (Basic)	$4.29
Earnings per Share (EPS) (Diluted)	$4.27
Balance Sheet Financials
Current Assets	$1.51B
Property, Plant, and Equipment	$733.24M
Long-Term Assets	$1.93B
Total Assets	$3.44B
Current Liabilities	$1.29B
Long-Term Debt	$299.87M
Long-Term Liabilities	$542.10M
Total Liabilities	$1.83B
Common Equity	$1.61B
Tangible Shareholders Equity	$1.10B
Shareholders Equity	$1.61B
Common Shares Outstanding	78.87M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$613.41M
Cash Flow from Investing Activities	$-59.04M
Cash Flow from Financial Activities	$-536.62M
Beginning Cash	$180.07M
End Cash	$196.93M
Increase/Decrease in Cash	$16.86M
Stock-Based Compensation	$32.43M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.17
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.16
Debt to Equity Ratio	0.60
Gross Margin	64.04%
Operating Margin	34.98%
EBIT Margin	34.98%
EBITDA Margin	--
Pre-Tax Profit Margin	34.29%
Profit Margin	27.82%
Free Cash Flow	$556.78M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.35
Inventory Turnover	1.12
Receiveable Turnover	1.94
Days Sales in Receivables	46.39
Return on Equity	20.99%
Return on Tangible Equity	30.67%
Return on Assets	9.83%
Return on Investments	17.70%
Book Value Per Share	$20.45
Free Cash Flow per Share	$7.02
Operating Cash Flow per Share	$7.73

Data from Zacks Investment Research, Inc.